Medi-Mind
ActiveSummary
Medi-Mind has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €48,439 and a net result of €34,440. Its solvency ranks better than 53% of 20,706 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
Overview
Official details
Source: KBO- Status
- Active since 15-03-2024 Normal situation
- Activity
- Specialist medical practice NACE 86220
- Establishment unit
- 2.357.489.186 2480 Dessel, since 15-03-2024
- Financial year end
- 31 December
- Peppol
- Reachable since 09-10-2026
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.1%
- Gross margin
- €42,386
- ▲ 244%
- Turnover
- ≈ €130,000
- estimated
- Profit
- €34,440
- ▲ 283%
- Equity
- €48,439
- ▲ 246%
- Total assets
- €73,530
- ▲ 87.0%
Score breakdownraises riskFounded in 2024Liquidity: current ratio 3.36, cash €1,775lowers riskSector: Human health activities (NACE 86)Figures for financial year 2025 (filed on 24-03-2026)Show the evidence
Checked score
About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 53% of them on solvency, 10% on liquidity, 80% on profitability and 96% on growth.
The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 2 accounts on average 82 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
Financials
Financials · financial year 2025, micro format
Annual accounts 2025 filed on 24-03-2026 PDF all 2 filings
Every figure per financial year
The operating result for 2025 is 3.5 times that of 2024.
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Investments
| Item | 2024 | 2025 |
|---|---|---|
| Tangible fixed assets | €1,254 | €755 |
| Depreciation and write-downs of the year | €68 | €253 |
Source: notes to the 2024 to 2025 annual accounts (statement of fixed assets)
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €68 | €253 | ▲ 273% |
| Other operating charges640/8 | €239 | €186 | ▼ 22.4% |
| Gross operating margin9900 | €12,332 | €42,386 | ▲ 244% |
| Operating profit (loss)9901 | €12,025 | €41,947 | ▲ 249% |
| Financial income75/76B | - | €900 | - |
| Recurring financial income75 | - | €900 | - |
| Financial charges65/66B | - | €27 | - |
| Recurring financial charges65 | - | €27 | - |
| Profit (loss) for the period before taxes9903 | €12,025 | €42,820 | ▲ 256% |
| Income taxes67/77 | €3,026 | €8,380 | ▲ 177% |
| Profit (loss) for the period9904 | €8,999 | €34,440 | ▲ 283% |
| Profit (loss) for the period to be appropriated9905 | €8,999 | €34,440 | ▲ 283% |
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Assets | |||
| Total assets20/58 | €39,328 | €73,530 | ▲ 87.0% |
| Fixed assets21/28 | €1,186 | €1,688 | ▲ 42.3% |
| Tangible fixed assets22/27 | €1,186 | €1,688 | ▲ 42.3% |
| Plant, machinery and equipment23 | €1,186 | €935 | ▼ 21.1% |
| Furniture and vehicles24 | - | €753 | - |
| Current assets29/58 | €38,141 | €71,842 | ▲ 88.4% |
| Amounts receivable after more than one year29 | - | €30,000 | - |
| Other amounts receivable291 | - | €30,000 | - |
| Amounts receivable within one year40/41 | €36,266 | €40,067 | ▲ 10.5% |
| Trade receivables40 | €17,132 | €40,067 | ▲ 134% |
| Other amounts receivable41 | €19,134 | - | - |
| Cash at bank and in hand54/58 | €1,876 | €1,775 | ▼ 5.4% |
| Equity and liabilities | |||
| Total equity and liabilities10/49 | €39,328 | €73,530 | ▲ 87.0% |
| Equity10/15 | €13,999 | €48,439 | ▲ 246% |
| Contributions10/11 | €5,000 | €5,000 | = |
| Reserves13 | €8,999 | €43,439 | ▲ 383% |
| Distributable reserves133 | €8,999 | €43,439 | ▲ 383% |
| Amounts payable17/49 | €25,328 | €25,091 | ▼ 0.9% |
| Amounts payable within one year42/48 | €19,402 | €21,350 | ▲ 10.0% |
| Trade debts44 | - | €3,472 | - |
| Suppliers440/4 | - | €3,472 | - |
| Taxes, remuneration and social security45 | €8,851 | €14,272 | ▲ 61.2% |
| Taxes450/3 | €8,851 | €14,272 | ▲ 61.2% |
| Other amounts payable47/48 | €10,551 | €3,606 | ▼ 65.8% |
| Accrued charges and deferred income492/3 | €5,927 | €3,740 | ▼ 36.9% |
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Profit (loss) for the period9904 | €8,999 | €34,440 | ▲ 283% |
| + Depreciation and write-downs630 | €68 | €253 | ▲ 273% |
| Operating cash flow (approximation) | €9,067 | €34,693 | ▲ 283% |
| Investment in fixed assets (approximation) | - | -€755 | - |
| Change in cash | - | -€100 | - |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.
Historical observation
In July 2024, 39,278 companies had the same profile as Medi-Mind has now. Two years later, 95.8% were still going and 1.8% had gone bankrupt.
- Micro
- 2 to 5 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
Another 0.1% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of Medi-Mind itself is lower: 0.1% within 12 months. It rests on far more data about Medi-Mind than the profile alone.
Test of the method
The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,278 companies, not a prediction for Medi-Mind. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Board & ownership
Directors
Owners and capital
Shareholders
- MEEUS Marisse Celine Marcel 100 shares (100%) · €5,000
Capital transactions
- 19-03-2024 Incorporation · €5,000 · 100 shares
Articles of association
- Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one. According to the deed, the legal criteria do not require one here.
- No statutory auditor
- Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
- “Elke belanghebbende kan provinciale raad informeren bij uitblijven oplossing, bestuurder(s) in functie als vereffenaar(s) krachtens statuten”
Articles of association, deed of 19-03-2024 (in Dutch)
Network & group
Medi-Mind shares no director with another company.
Connections & network
1 current directorThe network starts from the directors of Medi-Mind. Every other company they run is a node.
Timeline
Acts, filings and financial milestones
19-03
Gazette deed
IncorporationStarting capital €5,000 · Appointment: MEEUS Marisse Celine Marcel (director) · Founder11 points ▸
- Incorporation, “Medi-Mind” (deed in Dutch)
- Founder, MEEUS Marisse Celine Marcel
- Founding capital, €5,000
- Bank account, “bijzondere rekening geopend namens de vennootschap in oprichting”, 5000 (deed in Dutch)
- Capital
- Kind of shares, “op naam”, 100 (deed in Dutch)
- Other provision, “Slot-en overgangsbepalingen, eenparig door comparant” (deed in Dutch)
- Registered office clause, “2480 Dessel,Geelstraat 13” (deed in Dutch)
- Board rule, 1
- Director appointment, MEEUS Marisse Celine Marcel (director (not named in the articles))
- Other provision, “aanvaarding mandaat en afwezigheid beletsel, op vraag van de notaris” (deed in Dutch)
Sources:Publications in the Belgian Official GazetteFilings with the National Bank
History
Company details
Register details
Identity
KBO recordRegistered office and establishments
Activities
NACEBEL 20257 activities
- De uitoefening van de geneeskunde,meer bepaald de specialisatie pediatrie,door de artsen-aandeelhouders in naam en voor rekening van de vennootschap,rekening houdend met de regels van de medische deontologie en onder de specifieke beroepsaansprakelijkheid van de artsen-aandeelhouders en de bijkomende aansprakelijkheid van de vennootschap.
- Het ter beschikking stellen van alle nodige middelen aan de artsen,voor het beheren van een praktijk.Het inrichten van algemene diensten en een medisch secretariaat in het bijzonder,die nuttig of nodig zijn voor de uitoefening van voornoemde activiteiten;
- De aankoop,het huren,het leasen en het invoeren van alle medische apparatuur,toestellen en begeleidende accommodaties,inclusief gebouwen en transportmiddelen,voor de uitoefening van voornoemde activiteiten;
- De mogelijkheden scheppen om de artsen toe te laten zich verder te bekwamen in hun discipline,deel te nemen aan wetenschappelijke activiteiten en onderzoeken,teneinde in hun medische activiteiten bij te blijven;
- Het organiseren van lessen,opleidingen,seminaries,congressen in verband met de geneeskunde in het algemeen en met pediatrie in het bijzonder;
- Het occasioneel verstrekken van onderwijs en geven van lezingen over medische onderwerpen,het schrijven en laten publiceren van medische artikels en boeken,het optreden als stagebegeleider;
- Het ontwikkelen,kopen,verkopen,in licentie nemen of geven van octrooien,knowhow en aanverwante immateriële activa.
Invoicing and payment
Financial year and general meeting
Accounts at the NBBSites & property
Buildings and parcels at the address
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 13006E0770/00E000 | Flanders | 4,203 m² | 1 · 263 m² | 13.9 m · 2 |